Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lactoferrin and bone; structure-activity relationships.

J Cornish1, K Palmano, K E Callon

  • 1Department of Medicine, University of Auckland, Private Bag 92019 Auckland, New Zealand. j.cornish@auckland.ac.nz

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of function of male-specific lethal 3 (Msl3) does not affect spermatogenesis in rodents.

Developmental dynamics : an official publication of the American Association of Anatomists·2023
Same author

What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?

Expert opinion on drug safety·2022
Same author

The Moondance Bowel Cancer Project schools initiative.

Annals of the Royal College of Surgeons of England·2021
Same author

Bone-friendly lifestyle and the role of calcium or vitamin D supplementation.

Climacteric : the journal of the International Menopause Society·2021
Same author

Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Where have all the appendicectomies gone?

Annals of the Royal College of Surgeons of England·2021
Same journal

Reply to the discussion of "Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and metanalysis".

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same journal

Discussion of "Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis".

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same journal

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same journal

Distinct effects of disease-associated mutations in the proximal C-linker on negatively cooperative binding of cyclic nucleotides to the human HCN4 channel.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same journal

PPP2R2B targets the JAK2-STAT3 signaling pathway to regulate ferroptosis in breast cancer cells.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same journal

Suppression of CBP/p300 induces growth inhibition and autophagy of hepatocellular carcinoma cells through regulation of EPHA2 by its super-enhancer acetylation.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
See all related articles

Lactoferrin promotes bone growth and healing by stimulating osteoblasts and inhibiting osteoclasts. Its anabolic effects are mediated through multiple receptors and pathways, suggesting therapeutic potential for osteoporosis.

Area of Science:

  • Bone biology and skeletal remodeling
  • Cell signaling pathways in osteogenesis
  • Biomaterials and therapeutic agents for bone repair

Background:

  • Bone remodeling relies on balanced osteoblast and osteoclast activity, crucial for skeletal integrity.
  • Lactoferrin has demonstrated anabolic effects on bone, stimulating osteoblast proliferation and differentiation while inhibiting osteoclast formation.
  • Previous research indicated lactoferrin's mitogenic effects on osteoblasts are mediated by low-density lipoprotein-receptor protein-1 (LRP1) and involve MAPK and PI3K/Akt signaling.

Purpose of the Study:

  • To investigate the structural and functional properties of lactoferrin influencing its osteogenic activity.
  • To explore the diverse signaling pathways and potential multiple receptors involved in lactoferrin's anabolic skeletal effects.
  • To evaluate lactoferrin's potential physiological and therapeutic roles in bone growth, healing, and osteoporosis.

Related Experiment Videos

Main Methods:

  • Analysis of lactoferrin's osteogenic activity across different forms (deglycosylated, holo, apo) and fragments.
  • Investigation of structure-activity relationships to identify key molecular features for bone anabolic effects.
  • Examination of signaling pathways activated by lactoferrin in osteoblast-like cells.

Main Results:

  • Lactoferrin retains osteogenic activity in deglycosylated, iron-bound (holo), and iron-free (apo) forms, as well as in various molecular fragments.
  • These findings suggest lactoferrin interacts with multiple membrane-bound receptors to mediate its anabolic skeletal effects.
  • Lactoferrin activates diverse intracellular signaling pathways, contributing to its bone-promoting actions.

Conclusions:

  • Lactoferrin exhibits robust osteogenic activity, independent of its glycosylation state or iron-binding capacity.
  • The molecule signals through multiple receptors and diverse pathways, highlighting its complex role in bone metabolism.
  • Lactoferrin holds significant promise as a physiological factor in bone healing and as a therapeutic agent for osteoporosis.